I understand what you’re saying, but as far as I’m concerned and the roller we’ve all been on the last two years (some much longer)… there’s only two things that matter. They are no approval and approval… everything in between is fluff.
At this point, we need meaningful results along with some sort of approval to move the SP upward. I’m hopeful that will happen this year… and yes, I know we have a lot going on (trials, many different indications, etc)… but at this particular moment in time, it’s all fluff IMHO. The present SP speaks volumes.